Combination of two new therapies may be highly effective in advanced prostate cancer
Early results from a clinical trial presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that combining an immunotherapy with a targeted therapy may be highly...Read More
Immunotherapy and Prostate Cancer
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Checkpoint Inhibitors Miracle Drugs for Some, But Not Yet...Read More
Immunotherapy: Who’s Who in the Immune System
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Making sense of some very complicated stuff only...Read More
New three-in-one blood test opens door to precision medicine for prostate cancer
Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance...Read More
Immunotherapy: A Vaccine for Prostate Cancer
https://vimeo.com/731870460/f451d6b79c In this three part series, we examine the latest advances in immunotherapy, one of the most promising strategies in cutting edge cancer research, and it's affects on prostate...Read More
PCF study finds that adding a 22-gene test to standard prostate cancer risk groups improves accuracy of patient prognosis
A PCF study presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that using a 22-gene test along with standard prostate cancer risk group features vastly...Read More
Cancer patients who self-report symptoms to their doctors on a weekly basis live five months longer
A provocative study at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting reported that metastatic cancer patients who self-reported their symptoms to their doctors on a weekly basis...Read More
Abiraterone and Enzalutamide equivalent as first-line therapy in metastatic hormone therapy- resistant prostate cancer
A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that men who develop metastatic hormone therapy-resistant prostate cancer (mHRPC) have similar outcomes...Read More
Your Best Weapon Against Metastatic Prostate Cancer May Be a Genetic Counselor
Mark Meerschaert is alive today because of a genetic counselor, a medical oncologist in Seattle named Heather Cheng, M.D., Ph.D. (You can read more about Mark’s story here.) Less than...Read More
Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival
ASCO Perspective “For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,” said Sumanta Kumar Pal, MD,...Read More